Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SBP-101 by Spark Biopharma for Biliary Tumor: Likelihood of Approval
SBP-101 is under clinical development by Spark Biopharma and currently in Phase I for Biliary Tumor. According to GlobalData, Phase...
SBP-101 by Spark Biopharma for Hepatocellular Carcinoma: Likelihood of Approval
SBP-101 is under clinical development by Spark Biopharma and currently in Phase I for Hepatocellular Carcinoma. According to GlobalData, Phase...
SBP-101 by Spark Biopharma for Glioblastoma Multiforme (GBM): Likelihood of Approval
SBP-101 is under clinical development by Spark Biopharma and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...